Creative Planning Raises Position in Medical Properties Trust, Inc. (NYSE:MPW)

Creative Planning boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 0.7% during the second quarter, Holdings Channel reports. The institutional investor owned 27,554 shares of the real estate investment trust’s stock after buying an additional 185 shares during the period. Creative Planning’s holdings in Medical Properties Trust were worth $355,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. IFP Advisors Inc increased its stake in shares of Medical Properties Trust by 15.1% in the first quarter. IFP Advisors Inc now owns 9,009 shares of the real estate investment trust’s stock worth $116,000 after buying an additional 1,182 shares during the last quarter. Neuburgh Advisers LLC increased its stake in shares of Medical Properties Trust by 6.2% in the first quarter. Neuburgh Advisers LLC now owns 10,582 shares of the real estate investment trust’s stock worth $136,000 after buying an additional 616 shares during the last quarter. Greenwich Wealth Management LLC bought a new stake in shares of Medical Properties Trust during the first quarter worth approximately $141,000. Huntington National Bank increased its stake in shares of Medical Properties Trust by 70.1% in the first quarter. Huntington National Bank now owns 11,434 shares of the real estate investment trust’s stock worth $147,000 after buying an additional 4,712 shares during the last quarter. Finally, GW&K Investment Management LLC bought a new stake in shares of Medical Properties Trust during the first quarter worth approximately $148,000. 78.58% of the stock is currently owned by institutional investors and hedge funds.

Medical Properties Trust, Inc. (NYSE MPW) traded down 1.08% during midday trading on Tuesday, hitting $12.84. The company had a trading volume of 499,044 shares. The stock has a market cap of $4.12 billion, a PE ratio of 15.41 and a beta of 0.89. The stock’s 50-day moving average price is $12.98 and its 200-day moving average price is $13.05. Medical Properties Trust, Inc. has a 52-week low of $11.54 and a 52-week high of $15.74.

Medical Properties Trust (NYSE:MPW) last posted its earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Medical Properties Trust had a return on equity of 7.94% and a net margin of 41.79%. The firm had revenue of $156.40 million for the quarter, compared to analyst estimates of $156.91 million. During the same quarter in the prior year, the company earned $0.35 EPS. Medical Properties Trust’s revenue was up 15.9% on a year-over-year basis. On average, equities research analysts expect that Medical Properties Trust, Inc. will post $0.87 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 14th. Shareholders of record on Thursday, June 15th were issued a $0.24 dividend. The ex-dividend date of this dividend was Tuesday, June 13th. This represents a $0.96 annualized dividend and a yield of 7.40%. Medical Properties Trust’s dividend payout ratio (DPR) is presently 114.29%.

ILLEGAL ACTIVITY NOTICE: “[[title]]” was reported by [[site]] and is the sole property of of [[site]]. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at [[permalink]].

A number of analysts have recently commented on MPW shares. Royal Bank Of Canada restated a “buy” rating on shares of Medical Properties Trust in a research note on Monday, May 15th. Jefferies Group LLC upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Tuesday, July 4th. Deutsche Bank AG increased their price target on Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research report on Thursday, April 6th. BidaskClub upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a $13.00 price target on shares of Medical Properties Trust in a research report on Friday. Two analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company’s stock. Medical Properties Trust currently has an average rating of “Hold” and a consensus price target of $14.20.

In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the business’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.00% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).